Study of ACTR707 in Combination With Rituximab in Subjects With Relapsed or Refractory B Cell Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jessica Sachs, MD
Cogent Biosciences, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Banner Md Anderson Cancer Center
Gilbert, Arizona, United States
- Yale University
New Haven, Connecticut, United States
- Emory University, Winship Cancer Institute
Atlanta, Georgia, United States
- Loyola University
Maywood, Illinois, United States
- Indiana Bone and Marrow Transplantation
Indianapolis, Indiana, United States
- University of Maryland
Baltimore, Maryland, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- Ohio State University
Columbus, Ohio, United States
- Tennessee Oncology - Nashville
Nashville, Tennessee, United States
- the University of Texas Md Anderson Cancer Center
Houston, Texas, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 4 Oct 2017
- Primary completion
- 21 Sept 2020
- Completion
- 21 Sept 2020
- Last update posted
- 11 Oct 2021
- Registered enrollment
- 26
- Registry id
- NCT03189836
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.